Free Trial

Moderna (MRNA) SEC Filings & 10K Form

Moderna logo
$26.12 -0.49 (-1.84%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$26.16 +0.04 (+0.15%)
As of 08/8/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Moderna SEC Filings

DateFilerForm TypeView
08/01/2025
3:03 PM
Moderna (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2025
6:02 AM
Moderna (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/07/2025
3:59 PM
Mock James M (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2025
9:06 AM
Hussain Abbas (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/09/2025
3:20 PM
Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
3:36 PM
Hoge Stephen (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2025
4:16 PM
Mock James M (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2025
3:26 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2025
3:28 PM
Horning Sandra (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2025
5:31 AM
Moderna (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2025
5:47 AM
Moderna (Subject)
Form SCHEDULE 13G/A
04/30/2025
5:47 AM
BAILLIE GIFFORD & CO (Filed by)
BAILLIE GIFFORD & CO (Filed by)
Moderna (Subject)
Form SCHEDULE 13G/A
04/07/2025
3:18 PM
Mock James M (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
3:41 PM
Hoge Stephen (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
3:46 PM
Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
3:49 PM
Mock James M (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
3:33 PM
Bancel Stephane (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
6:11 AM
Moderna (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/21/2025
6:14 AM
Moderna (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/14/2025
3:15 PM
Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:30 AM
Moderna (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2025
8:07 AM
BAILLIE GIFFORD & CO (Filed by)
Moderna (Subject)
Form SCHEDULE 13G/A
01/13/2025
6:03 AM
Moderna (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2025
3:38 PM
Mock James M (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
2:18 PM
Klinger Shannon Thyme (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/06/2024
3:51 PM
Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2024
3:55 PM
Mock James M (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
2:23 PM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/02/2024
3:26 PM
Mock James M (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2024
3:15 PM
Hoge Stephen (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2024
3:19 PM
Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2024
2:49 PM
Klinger Shannon Thyme (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/29/2024
2:54 PM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/29/2024
2:35 PM
Mock James M (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/07/2024
5:33 AM
Moderna (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/08/2024
3:19 PM
Mock James M (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
7:49 AM
Hussain Abbas (Reporting)
Moderna (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/04/2024
7:52 AM
Hussain Abbas (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
6:03 AM
Moderna (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2024
5:03 AM
Moderna (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2024
3:15 PM
Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Your blueprint for crypto wealth (Ad)

Mark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…

Claim your pass to the Crypto Community Summit here (free for a limited time)
09/09/2024
2:29 PM
Klinger Shannon Thyme (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/04/2024
4:42 PM
Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
3:26 PM
Hoge Stephen (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
2:42 PM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/30/2024
3:34 PM
Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2024
3:37 PM
Mock James M (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2024
3:45 PM
Mock James M (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/28/2024
3:30 PM
Klinger Shannon Thyme (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/13/2024
3:33 PM
Hoge Stephen (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:MRNA) was last updated on 8/9/2025 by MarketBeat.com Staff
From Our Partners